Cost-effectiveness of chronic hepatitis C screening and treatment

Hepatitis C virus (HCV) infection is the second most common cause of chronic liver disease in South Korea, with a prevalence ranging from 0.6% to 0.8%, and HCV infection incidence increases with age. The anti-HCV antibody test, which is cheaper than the HCV RNA assay, is widely used to screen for HC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Association for the Study of the Liver 2022-04-01
Colecção:Clinical and Molecular Hepatology
Assuntos:
cost-effectiveness
hepatitis c
screening
Acesso em linha:http://e-cmh.org/upload/pdf/cmh-2021-0193.pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados